SANOFI DIABETES_

Contact PR

To use this feature, join Babbler easily !

Download this content

Press release

Media information: Sanofi Toujeo medical treatment
timer minutes reading time

Copy link

Switching to Toujeo® in a real-world setting produced a similar number of severe low blood sugar events as insulin degludec 

Two large real-world analyses compared adults with type 2 diabetes who were switched to Toujeo (insulin glargine injection 300 Units/mL) to those switched to insulin degludec 

  • Health & Medicine
  • Medicine
  • Men's Health
  • Women's Health